MetLife Institutional Funding II said it would sell a benchmark-sized offering of floating-rate notes on Tuesday.

The three-year issue is expected to be sold in the private placement Rule 144a market later this session via sole bookrunner Barclays Capital.

Preliminary pricing guidance suggests a risk premium of 90 basis points over the three month London Interbank Offered rate.

Proceeds will be used for general corporate purposes, which could include the repayment of outstanding debt securities.

The deal has been rated Aa3 by Moody's Investors Service and AA- by Standard & Poor's.

-By Kellie Geressy-Nilsen; Dow Jones Newswires; 212 416-2225; kellie.geressy@dowjones.com

 
 
MetLife (NYSE:MET)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more MetLife Charts.
MetLife (NYSE:MET)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more MetLife Charts.